WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (NASDAQ: INCY) today announced that its second quarter financial results conference call and webcast are scheduled for July 2024, ET Held on Tuesday, March 30th at 8:00 am.
The schedule for press releases and conference calls/webcasts is as follows:
- 2024 Q2 Press Release: July 30, 2024, 7:00 AM ET
- 2024 Second Quarter Conference Call: July 30, 2024, 8:00 a.m. ET
- Domestic dial-in number: 877-407-3042
- International dial-in number: 201-389-0864
- Conference ID number: 13747471
If you are unable to attend, a replay of the conference call will be available for thirty days. The replay dial-in number for the United States is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay, you need meeting ID number 13747471.
The webcast with slideshows will be available for viewing at Investor.Incyte (NASDAQ:).com and will be available for replay for ninety days.
About Incyte
A global biopharmaceutical company whose mission is to solve., Incyte follows science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapies, Incyte has built a best-in-class portfolio of medicines for patients and built strong pipelines in oncology, inflammation and autoimmunity. Incyte is headquartered in Wilmington, Delaware, with operations in North America, Europe and Asia.
For more information about Incyte, visit Incyte.com or follow us on social media: LinkedIn, XInstagram, Facebook (NASDAQ: ), YouTube.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240709787662/en/
media
media@incyte.com
investor
ir@incyte.com
Source: Incyte
